Volume 46, Number 12, 1662-1668, DOI: 10.1007/s00125-003-1244-z

Published in partnership with the

Logo

European Association for the Study of Diabetes

Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance

T. Ferre, E. Riu, S. Franckhauser, J. Agudo and F. Bosch

View Related Documents

Abstract

Aims/hypothesis  

Glucokinase overexpression in the liver increases glucose uptake and utilization, and improves glucose tolerance in young transgenic mice. Here, we examined the long-term effects of hepatic overexpression of glucokinase on glucose homeostasis. Moreover, we determined whether glucokinase overexpression counteracted high-fat diet-induced insulin resistance.

Methods  

Transgenic mice overexpressing glucokinase in liver under the control of the phosphoenolpyruvate carboxykinase promoter, fed either a standard diet or a high-fat diet, were studied. We used non-transgenic littermates as controls.

Results  

Transgenic mice over 6 months old developed impaired glucose tolerance. In addition, at 12 months of age, transgenic mice showed mild hyperglycaemia, hyperinsulinaemia and hypertriglyceridaemia. In spite of increased glucokinase activity, the liver of these mice accumulated less glycogen and increased triglyceride deposition. When 2-month-old glucose-tolerant mice were fed a high-fat diet, transgenic mice gained more body weight and became hyperglycaemic and hyperinsulinaemic. This was concomitant to glucose intolerance, liver steatosis and whole-body insulin resistance.

Conclusion/interpretation  

Long-term overexpression of glucokinase increases hepatic lipogenesis and circulating lipids, which lead to insulin resistance. Our results also suggest that the liver plays a key role in the onset of diabetes.

Keywords  Transgenic mice - glucokinase - high-fat diet - glucose metabolism - insulin resistance - Type 2 diabetes

Fulltext Preview

Image of the first page of the fulltext document